The role of fibronectin in hemostasis

V. P. Baluda , A. P. Melnikov , T. B. Lukoyanova

Kazan medical journal ›› 1984, Vol. 65 ›› Issue (3) : 213 -217.

PDF
Kazan medical journal ›› 1984, Vol. 65 ›› Issue (3) : 213 -217. DOI: 10.17816/kazmj89046
Reviews
review-article

The role of fibronectin in hemostasis

Author information +
History +
PDF

Abstract

Over the past 10-15 years, researchers in the field of experimental and clinical medicine have shown increased interest in fibronectin —FN), a blood plasma protein with a diverse biological effect. FN is a glycoprotein found both in the blood and in other body fluids, and in an insoluble form - in connective tissue, in particular as part of the basement membrane [28, 30, 48, 69]. The main source of plasma FNL are endothelial cells and hepatocytes. FN ensures the convergence and adhesion of cells, contributing to the elimination of vascular endothelial defect in normal condition and after injury. Its molecular weight is about 4.4-105 daltons, the sedimentation constant is 12-14S, the isoelectric point is 5.5-6.2; it belongs to the class of mobile β-globulins [44c]. The function of this protein in the human body is diverse. This can be judged, in particular, by the number of available synonyms, each of which reflects a certain biological property of the protein: cold-insoluble globulin, anti-gelatin factor, microfibrillary protein, protein with opsonin properties, fibroblast surface antigen, galactoprotein a, cell attachment factor, large external transformation-sensitive protein, cell surface protein, cell proliferation factor [28, 64]. The preferred term is "fibronectin", which means "fiber binding" (from Lat. fibra- fiber-nectere - binding) [23, 30, 41]. Plasma FN together with fibrinogen, factor XIII, and Willebrand factor is precipitated from plasma at 0° 25% with ammonium sulfate [44a] or 8% ethanol [43]. Its concentration in the cryoprecipitate increases 5-10 times [43], in the plasma of healthy men is 180-720 mg / l, in women - 150-540 mg / l, in serum - 20-50% less than in plasma.

Keywords

Kazan Medical archive

Cite this article

Download citation ▾
V. P. Baluda, A. P. Melnikov, T. B. Lukoyanova. The role of fibronectin in hemostasis. Kazan medical journal, 1984, 65(3): 213-217 DOI:10.17816/kazmj89046

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Alexander L. М. а. о. Ann. Surg., 1976, 184, 6.

[2]

А1itа1о K-, Ноѵі Т., Vaher і А. J. exp. Med., 1980, 151,

[3]

Arneson M. A. a. о. J. A. M. A. 1980, 244, 2.

[4]

Balian G., Click E. M., Bornstein P. J. Biol. Chem., 1980, 255, 8.

[5]

Bensusan H. B. a. o. Proc. Natl Acad. Sei., USA, 1978, 75, 12.

[6]

B1umenstock F. A., Weber P., Saba T. M. Am. J. Physiol., 1977, 232, 3.

[7]

Blumenstock F. A4 Saba T. M., Weber P. J. Reticuloendot. Soc., 1978, 23,2.

[8]

Bray B. A. a) Ann. NY Acad. Sei, 1978, 312, 4; b) J. clin. Invest., 1978, 62,4.

[9]

Carter W. G. J. biol. Chem., 1982, 257, 22.

[10]

Clawson С. C., White J. G., Hergberg M. C. Am. J. Hematol., 1980, 9, 1.

[11]

Cohen J. a. o. J. Lab. clin. Med., 1981, 97, 1.— 1. Duckert F. Ann. NY Acad. Sei., 1972, 202, 3.

[12]

EdsallJ. T., Gilbert G. A., Scherada H. A. Amer. Chem. Soc., 1955, 77, 1.

[13]

Ehrlich M. J. a. o. J. Lab. clin. Med., 1981, 98, 2.

[14]

Furie M. B., Frey A. B., Rifrin D. B. J. biol. Chem., 1980, 255, 10.

[15]

Cans H. Surgery, 1966, 60, 6.

[16]

Ginsberg M. H. a. o. a) J. Supramol. Struct., 1979, 11, 167; b) Proc. Natl. Acad. Sei. USA, 1980, 77, 2,

[17]

Gordenne W., Foidart J. M„ Lapiere C. M. J. Gyn. Obst. Biol. Reprod., 1982, 11, 5.

[18]

Gordon J. L. Nature, 1979, 278, 5699.

[19]

Grinnell F., Feld M., Snell W. Cell. Biol. Int. Rep., 1979,3,585.

[20]

Grinnell F., Feld M., Minter D. Cell, 1980, 19, 2.

[21]

Grinnell F, Feld M. Thromb. Res., 1981,24, 5—6.

[22]

Grouse L. D. J. A.M.A., 1980,244,

[23]

Hawiger J. a. o. J. Lab. clin. Med., 1970, 75, 1.

[24]

Hawiger J., Hammoud D. K-, Timmons S. Nature, 1975, 258. 5536.

[25]

Hayashi M., Yamada K- M. J. biol. Chem., 1982, 257, 9,

[26]

Hoermann H., Ji1ek F.Excepta Medica, 1981, 24, 10.

[27]

Hynes R. O. Biochim. biophys Acta, 1976, 458, 73. 29 Jaffe E. A., Mosher D. F. J. exp. Med., 1978, 147, 6.

[28]

Jamada K. Ä, Oiden K. Nature, 1978,275,5677.

[29]

J wanada S„ Su guki K-, Hashimoto ъ. Ann. NY Acad. Sei., 1978, 312, 56.

[30]

Kaplan J. E., Saba T.-M. a) Phisiologist, 1977, 20, 4; b) Am. J. Physiol., 1978, 234, 4; c) Jbid., 253. 3

[31]

Kaplan J. t.,Snedeker R. W J. Lab. clin. Med., 1980, 96, 6,

[32]

Komtts J. a. o. J. clin. Invest., 1978 62 6,

[33]

Kunsela P. Nature, 1978, 276, 5689.

[34]

Lavah J, Hynes R. O. Excepta Medica, 1982, 26, 10,

[35]

Lee L. J. exp. Med., 1962, 115, okП de Г Mirttinen A., Tornroth T. J. lab. Invest., 1980, 42, 1.

[36]

Mc Donald J. A., Kelly D. G. J. biol. Chem., 1980, 255, 18,

[37]

Morrison P. R. E d s а 1 1 J. T., Milter S. G. J. Amer. Chem. Soc., 1948, 70, 9.

[38]

Mоsesson М. W. Ann. NY Acad. Sei., 1978, 312, IL

[39]

Mosesson M. W., Co1man R. W., Sherry S. S. N. Engl. J. Med., 1968, 278, 15,

[40]

Mosesson M. W., bmfle,A J‘ bio1- Chem., 1970, 245, 21,

[41]

Mosher D. F. a) J. Biol. Chem., 1975, 250, 16; b) Ibid., 1976, 251, 6; c) Progr. Hemosf. Thromb., 1980, 5, 111.

[42]

Mosher D. F; Schad P. E., Kleinman H. K- J. clin. Invest, 1979, 64, 3.

[43]

Mocher D. E.,Schad P. E., Vann J. M. J. biol. Chem., 1980, 255, 3.—Nasu K., Latouг I. J.,Mc Kay D. G.Am.J. Obstet. Cynec., 1971, 109, 7.—Pear1stein E.,GoldL. I., Сarcia-Pardо A. Mol. Cell. Biochem., 1980,29, 3

[44]

P1w E.F. a. o.J. clin.Invest.,1979,63, 3,

[45]

Plow E. F., Ginsberg M. N. J, biol. Chem., 1981, 256, 18,

[46]

Pо11 G. a. o. Dtsch Med. Wschr., 1981, 106, 17,

[47]

Proctor R. A., Mоsher D. F., O11rant g P. J. J. biol. Chem., 1982, 257, 24,

[48]

Saba T. M. Arch, inter. Med., 1970, 126, 6,

[49]

Saba T. M. Dilugio N. R. Ann. Physiol., 1969, 216, 1,

[50]

Saba T. M. a. o. Ann. NY Acad. Sei., 1978, 312, 43.

[51]

Saba T. M., Laffe E. Am. J. Med., 1980, 68, 4.

[52]

Santoro S. A., Cunningham L. W. Proc. Nac. Acad. Sei, USA, 1979, 76, 6.

[53]

Schumacher P. T., Saa T. M. Physiologist, 1977, 20, 4.

[54]

ScкiguchiK-, Fukuda M., Hakomori S. J. biol. Chem., 1981, 256, 12.

[55]

Scovill W. A. a. 0. J. Trauma, 1976, 16, 11.

[56]

Sherman L. A. Thromb. Hemost., 1977, 38, 4.

[57]

Sherman L. A., Lee I. Ibid., 1979, 42, 1.

[58]

Smith D. E., Furcht L. T. J. biol. Chem., 1982, 257, 11.

[59]

Sochynski R. A. a. o. Thromb. Res., 1980, 18, 3—4.

[60]

Stathakis N. E., Mosesson M. W. J. clin. Invest., 1977, 60, 855.

[61]

Stathakis N. E. a. o. Blood, 1978, 51, 6.

[62]

Stathakis N. E., Fonntai 0 A., Tsianоs E. J. clin. Pathol., 1981, 34, 5.

[63]

Stenman S., Smitten K., Vaheri A. Acta Med. Scand., 1980, Suppl., 642.

[64]

Vaher i A., Mosher D. F. Biochim. biophys. Acta, 1978, 516, 1.

[65]

Vaher i A. Schweis. Med. Wochenschr., 1980, 110, 40.

[66]

Zucker M. B. a. o. Blood, 1979, 54, 1.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

112

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/